Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier
International Journal of Molecular Sciences · 14.09.2023 · 24 (18) · 14117
DOI: 10.3390/ijms241814117 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.09.2023. Verfasst von Pablo Vargas-Rodríguez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Parasitology and Biomedicine Lopez-Neyra (IPBLN), CSIC, PT Salud, 18016 Granada, Spain. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinson Disease, Alzheimer Disease, Mesenchymal Stem Cells. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 256 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Science and Innovation, PhD fellowship, Next Generation EU.
Abstract (Originalsprache)
Neurodegenerative disorders encompass a broad spectrum of profoundly disabling situations that impact millions of individuals globally. While their underlying causes and pathophysiology display considerable diversity and remain incompletely understood, a mounting body of evidence indicates that the disruption of blood-brain barrier (BBB) permeability, resulting in brain damage and neuroinflammation, is a common feature among them. Consequently, targeting the BBB has emerged as an innovative therapeutic strategy for addressing neurological disorders. Within this review, we not only explore the neuroprotective, neurotrophic, and immunomodulatory benefits of mesenchymal stem cells (MSCs) in combating neurodegeneration but also delve into their recent role in modulating the BBB. We will investigate the cellular and molecular mechanisms through which MSC treatment impacts primary age-related neurological conditions like Alzheimer’s disease, Parkinson’s disease, and stroke, as well as immune-mediated diseases such as multiple sclerosis. Our focus will center on how MSCs participate in the modulation of cell transporters, matrix remodeling, stabilization of cell-junction components, and restoration of BBB network integrity in these pathological contexts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Parasitology and Biomedicine Lopez-Neyra (IPBLN), CSIC, PT Salud, 18016 Granada, Spain.
- Maimonides Biomedical Research Institute of Cordoba (IMIBIC), 14004 Cordoba, Spain.
- Department of Cell Biology, Physiology, and Immunology, University of Cordoba, 14004 Cordoba, Spain.
- Reina Sofia University Hospital (HURS), 14004 Cordoba, Spain.
- CIBER Physiopathology of Obesity and Nutrition (CIBERobn), 14004 Cordoba, Spain.
ORCID-Profile: Pablo Vargas-Rodríguez, Julia Castillo-González, Ignacio Serrano-Martínez, Raúl M Luque, Mario Delgado, Elena González-Rey
Förderung
- Spanish Ministry of Science and Innovation
- PhD fellowship
- Next Generation EU
Zitieren
APA
Vargas-Rodríguez, P., Cuenca-Martagón, A., Castillo-González, J., Serrano-Martínez, I., Luque, R. M., Delgado, M., & González-Rey, E. (2023). Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier. International Journal of Molecular Sciences, 24(18), 14117. https://doi.org/10.3390/ijms241814117
Vancouver
Vargas-Rodríguez P, Cuenca-Martagón A, Castillo-González J, Serrano-Martínez I, Luque RM, Delgado M, et al. Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier. International Journal of Molecular Sciences. 2023;24(18):14117. doi:10.3390/ijms241814117
BibTeX
@article{VargasRodrguez2023,
author = {Vargas-Rodríguez, Pablo and Cuenca-Martagón, Alejandro and Castillo-González, Julia and Serrano-Martínez, Ignacio and Luque, Raúl M and Delgado, Mario and González-Rey, Elena},
title = {Novel Therapeutic Opportunities for Neurodegenerative Diseases with Mesenchymal Stem Cells: The Focus on Modulating the Blood-Brain Barrier},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {14117},
doi = {10.3390/ijms241814117}
}
EUVIMED